fbpx

Changes to paracetamol scheduling will reduce risk of harm to children and adolescents

31 January 2025

 

Paracetamol is one of the medicines most frequently responsible for hospital admissions due to poisoning, a new report from the peak body for Australian pharmacists has found, with approximately 16 per cent of pharmaceutical poisoning hospital admissions in children under five years of age being attributed to paracetamol.

 

The Medicine safety: Children and adolescent care report released by the Pharmaceutical Society of Australia today further reveals that an estimated 93 children present to Australia’s emergency departments each day due to medicine-related problems, with approximately 40 admitted to hospitals. At least half of these incidents are preventable.

 

The report comes as federal government changes to paracetamol pack sizes come into effect, limiting the amount of paracetamol stored in Australian households and reducing the risk of intentional and unintentional harm including in children and adolescents. PSA joined Assistant Minister for Health and Aged Care Ged Kearney at Westgarth Pharmacy in Melbourne to launch the report and discuss paracetamol changes.

 

Effective from 1 February 2025, general sale pack sizes available from supermarkets or grocery stores will be reduced from 20 to 16 tablets, and Pharmacy Medicine packs will be limited to 50 tablets, with larger packs requiring pharmacist supervision (Pharmacist Only Medicine).

 

Paracetamol tablets in general sale packs and Pharmacy Medicine packs will also be required to be in blister packaging. Blister packaging can reduce overdose and impulsive attempts to self-harm by slowing the consumption of multiple tablets or capsules.

 

As the peak body for all Australian pharmacists, PSA strongly supports the move which will reduce the risk of overdose and poisoning, but there is more to be done.

 

 

 

Quotes attributable to PSA National President Associate Professor Fei Sim FPS:

 

“The sobering reality is that we are leaving our kids vulnerable to harm, particularly when it comes to common medicines around the house.

 

“By limiting the maximum pack sizes of paracetamol, we are opening the door to have a conversation about the risks and benefits of these medicines – both in the pharmacy and at home – and take steps as a community to promote the safe use of medicines.

 

“By involving pharmacists in the supply of larger paracetamol pack sizes, we strike the right balance between access and safety, giving pharmacists and pharmacy assistants the opportunity to help patients manage their pain effectively while reducing the risk of misuse and harm.

 

“As the peak body for all pharmacists in all areas of practice, PSA continues to advocate for pharmacists to be further empowered in their roles as medicine safety experts. This includes the recommendations PSA makes in our report, from implementing a national reporting system for medicine safety incidents, to increasing the availability of pharmacists in children’s hospital wards.

 

“It takes all of us, across health professions, communities and policymakers, to make a difference to the children and adolescents who rely on our care.”

 

Quotes attributable to Assistant Minister for Health and Aged Care, Ged Kearney MP:

 

“Each year in Australia around 225 people are hospitalised with liver injury and 50 people die from paracetamol overdose. To think of so many young lives lost is heartbreaking.

 

“The TGA’s decision to limit the size of paracetamol packs struck a balance between protecting young Australians from harm while also ensuring those in pain can access the medicine. My thanks to the TGA for its sensible and measured decision, and to the pharmacists and retailers around the country who have responded so robustly.”

 

Key findings from the Medicine safety: Children and adolescent care report:

  • Medicine-related problems in children and adolescents cost the Australian economy at least $130 million annually.
  • An estimated 93 children present to Australia’s emergency departments each day due to medicine-related problems, with approximately 40 admitted to hospitals. At least half of these incidents are preventable.
  • Paracetamol is responsible for approximately 16 per cent of pharmaceutical poisoning hospital admissions in children under five years of age.
  • Poisoning by non-opioid analgesics, antipyretics or antirheumatics was the leading cause of admission, with paracetamol accounting for at least 85% of the cases within this group.

 

The full Medicine safety: Children and adolescent care report is available here.

 

PSA media contact: Georgia Clarke M: 0480 099 798 E: georgia.clarke@psa.org.au

Assistant Minister Kearney media contact: Isabella Tilley 0414 894 040

Nearly 34,000 children presenting to emergency departments each year due to medicine problems, new report finds

31 January 2025

 

An estimated 93 children present to Australia’s emergency departments each day due to medicine-related problems, with approximately 40 admitted to hospitals, according to a new report from the peak body for Australian pharmacists.

 

The Medicine safety: Child and adolescent care report released by the Pharmaceutical Society of Australia today reveals the extent of medicine-related problems in children and adolescents, costing the Australian economy at least $130 million each year.

 

In the past six months alone, approximately 120,000 Australian children under 14 years old have experienced an adverse event due to medicines.

 

The report calls for Australia’s health system to be better equipped to deal with medicine safety challenges, with recommendations for action including the implementation of a national incident reporting and learning system, so that when children are harmed by medicines, health professionals and systems learn how to prevent another child suffering the same harm. This would bring Australia in line with many of our international peers, including Canada who have had the Assurance and Improvement in Medication Safety (AIMS) program in place since 2019.

 

Further recommendations also call for increased availability of pharmacists in paediatric wards of hospitals, as well as mandatory indication on prescriptions for children and adolescents, and mandatory manual dose checks during dispensing of paediatric prescriptions.

 

PSA National President Associate Professor Fei Sim FPS said the report’s findings painted a sobering reality of medicine use in Australia’s children and adolescents, showing the urgent need for reform.

 

“As the peak body for all pharmacists in all areas of practice, PSA continues to advocate for pharmacists to be further empowered in their roles as medicine safety experts.

 

“Our health system is failing children and adolescents. As a health community, we must commit to doing better, but we also need to be given the resources and tools to do better. Pharmacists are critical to ensure the safe use of medicines and must be supported to do so.

 

“That means adequately staffing children’s hospital wards with the expertise of pharmacists, investing in systems that capture the data needed for evidence-based policy, and improving the quality use of medicines whenever medicines are used.

 

“It takes all of us, across all areas of practice and indeed across all health professions, to make a difference to the children and adolescents who rely on our care,” Associate Professor Sim concluded.

 

The full Medicine safety: Child and adolescent care report is available at www.psa.org.au/medicine-safety-child-adolescent-care-report/

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Australians encouraged to know their medicines this World Patient Safety Day

17 September 2024

 

On World Patient Safety Day (17 September), pharmacists are encouraging Australians to take three simple steps to limit their risk of medicine misadventure.

 

Each year 250,000 Australians are hospitalised and a further 400,000 present to emergency departments with medicine-related programs, costing the Australian economy approximately $1.4 billion annually. It is estimated that at least half of these hospitalisations are preventable.

 

The Pharmaceutical Society of Australia (PSA) encourages patients to speak to their local pharmacist to learn more about the medications they use, including medicine interactions.

 

PSA National President Associate Professor Fei Sim FPS said pharmacists are experts in helping patients manage their medicines to ensure they are used safely and effectively.

 

“Today we’re urging Australians to know your medicines, the dose you have been prescribed, check medicine interactions, and for those who use multiple medicines, ask your GP about an annual Home Medicines Review which can be provided free of charge to you by a credentialed pharmacist,” she said.

 

“World Patient Safety Day is a great reminder for all Australians to check that they know the doses of their regular medications, and to ask their local pharmacist about possible medicine interactions.

 

“Older people and people living with a disability are more likely to be using more medicines, facing an increased risk of medicine interactions and misadventure. It is priority health populations like these that we particularly urge to see a pharmacist at least annually to review their medicines.

 

“Pharmacists are Australia’s medicines experts, and are here to provide trusted advice to all Australians about the medicines you use.”

 

​More information and research about medicine-related harm in Australia is available at www.psa.org.au/medicine-safety

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Quality Use of Medicines Alliance funded to promote health literacy

9 October 2023

 

Two new grants to support consumer health literacy and improve the use of medicines will see peak health and consumer organisations working side-by-side.

 

The Quality Use of Medicines Alliance represents a group of eight health and consumer organisations, bringing together unique expertise from education providers, consumer groups, researchers, health professionals, peak bodies and member organisations to develop free health education products for a national audience of health professionals and consumers.

 

The grants will run over a 2-year period and address priority quality use of medicines issues for atopic dermatitis, gout, antidepressants in older people and oral anticoagulants, awarded under the Australian Government’s Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program.

 

Pharmaceutical Society of Australia (PSA) National President Dr Fei Sim FPS said that improving the Quality Use of Medicines requires all health professionals working together.

 

“PSA is proud to be part of the Quality Use of Medicines Alliance, awarded health professional education and consumer health literacy grants by the Department of Health and Aged Care to improve health literacy and education,” Dr Sim said.

 

“Evidence shows that when health professionals and consumers work together, we can support more effective healthcare, better medicine safety and improved health outcomes.

 

“We are working with the Quality Use of Medicines Alliance to close knowledge gaps in atopic dermatitis, gout, oral anticoagulants, and antidepressants in older people.

 

“Through this work, PSA is proudly supporting pharmacists to not only champion safe and effective medicine use, but also to support health literacy and information for our patients.”

 

The Quality Use of Medicines Alliance consists of:

 

  • Medcast: a nationwide provider of independent education for a range of health professions
  • Health Care Consumers’ Association: a peak health consumer organisation working to improve the quality and safety of health care
  • Arthritis Australia: the leading national arthritis charity supporting people living with all types of arthritis
  • Eczema Support Australia: a national support network advocating for people living with eczema
  • Pharmaceutical Society of Australia: the national peak professional pharmacy body representing Australia’s 36,000 pharmacists across all sectors and specialisations
  • QUM Connect: a specialist consultancy with experience and expertise in creating and implementing quality use of medicines initiatives to improve health outcomes
  • Royal Australian College of General Practitioners: Australia’s largest professional general practice organisation responsible for maintaining standards for quality clinical practice, education and training, and research in Australian general practice
  • Wiser Healthcare: a research collaboration involving the University of Sydney, Bond University, Monash University and the University of Wollongong, with a special interest in research in the areas of rational test ordering and quality use of medicines.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au